Cardiac Biotech Solutions Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2018	FY 2017
Period Ending	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Net Income	-1.13	-0.39
Depreciation & Amortization	0	0
Change in Accounts Receivable	-0	0.01
Change in Inventory	0.02	-0
Change in Accounts Payable	0.02	0.13
Change in Other Net Operating Assets	0.32	0.18
Operating Cash Flow	-0.77	-0.06
Capital Expenditures	-0	-0
Sale (Purchase) of Intangibles	-0	-
Investing Cash Flow	-0.01	-0
Short-Term Debt Issued	0.36	0.08
Total Debt Issued	0.36	0.08
Short-Term Debt Repaid	-0.28	-
Total Debt Repaid	-0.28	-
Net Debt Issued (Repaid)	0.09	0.08
Issuance of Common Stock	0.68	-
Financing Cash Flow	0.77	0.08
Miscellaneous Cash Flow Adjustments	-	-0
Net Cash Flow	-0.01	0.01
Free Cash Flow	-0.77	-0.06
Free Cash Flow Margin	-2109.05%	-191.28%
Free Cash Flow Per Share	-0.01	-0.00
Levered Free Cash Flow	-0.02	-
Unlevered Free Cash Flow	-0.02	-
Change in Net Working Capital	-0.69	-

Updated Mar 5, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.